In a groundbreaking announcement, BioSkryb Genomics has partnered with Tecan Group to unveil a revolutionary single-cell multiomics workflow that promises to expedite the journey towards sequencing-ready libraries. This innovation can dramatically cut down the processing time to under ten hours, significantly boosting the potential of genomic research.
The Partnership that Promises Change
BioSkryb and Tecan’s collaboration is set to redefine the landscape of genomics research. By integrating BioSkryb’s advanced 384-well format with Tecan’s state-of-the-art robotic systems, researchers can now achieve unprecedented throughput and efficiency. The ResolveOME™ Whole Genome Amplification technology is at the heart of this transformation, offering a scalable solution tailored for high-throughput applications.
The Technology Behind the Innovation
At the core of this synergy lies BioSkryb’s ResolveOME™, a cutting-edge technology that amplifies DNA from individual cells. Coupled with Tecan’s automated liquid handling systems, this method streamlines the traditional labor-intensive process, providing scientists with the tools needed to handle larger sample sizes without compromising accuracy or quality.
Benefits to the Scientific Community
This new workflow is expected to have a profound impact on genomic studies across various research fields. By reducing the time required for library preparation, scientists gain more time for data analysis and interpretation, potentially accelerating discoveries in fields such as personalized medicine, cancer research, and beyond.
Embracing a New Era of Genomics
The introduction of this workflow marks a notable shift towards more efficient research processes. It empowers scientists with the capability to explore multiomic data at an accelerated pace, supporting the ever-growing demands for high-resolution genomic data. This development not only promises to advance academic research but also holds significant implications for the biotech industry.
As stated in News-Medical, this partnership underscores the power of technological innovation in unlocking new frontiers in genomics. As the scientific community eagerly anticipates the full integration of this workflow, it’s evident that the future of genomics research is brighter, faster, and more comprehensive than ever before.